Market success of Novo Nordisk’s obesity drug likely to be delayed in Japan, says GlobalData
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Marks the World Head & Neck Cancer Day at the OCTF Conference
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
This transformation will enable GE HealthCare to build a strong foundation for business growth
Advances clinical research capabilities with leading regulatory grade registries platform
PEEK brings a new quality to dental care for patients
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Subscribe To Our Newsletter & Stay Updated